Meri Rogava
Meri Rogava
Columbia University Medical Center
Verified email at - Homepage
Cited by
Cited by
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ...
Nature 507 (7490), 109-113, 2014
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ...
Nature 490 (7420), 412-416, 2012
Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy
N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ...
Immunity 47 (4), 789-802. e9, 2017
A molecular single-cell lung atlas of lethal COVID-19
JC Melms, J Biermann, H Huang, Y Wang, A Nair, S Tagore, I Katsyv, ...
Nature 595 (7865), 114-119, 2021
A single-cell landscape of high-grade serous ovarian cancer
B Izar, I Tirosh, EH Stover, I Wakiro, MS Cuoco, I Alter, C Rodman, ...
Nature Medicine 26 (8), 1271-1279, 2020
A stochastic model for immunotherapy of cancer
M Baar, L Coquille, H Mayer, M Hölzel, M Rogava, T Tüting, A Bovier
Scientific reports 6 (1), 1-10, 2016
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
CJ Frangieh, JC Melms, PI Thakore, KR Geiger-Schuller, P Ho, ...
Nature genetics 53 (3), 332-341, 2021
A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast CellsMelanoma Phenotype–Dependent Mast Cell Recruitment
M Hölzel, J Landsberg, N Glodde, T Bald, M Rogava, S Riesenberg, ...
Cancer research 76 (2), 251-263, 2016
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor ActivityTargeting Haspin for Cancer Therapy
JC Melms, S Vallabhaneni, CE Mills, C Yapp, JY Chen, E Morelli, ...
Cancer research 80 (4), 798-810, 2020
A stochastic individual-based model for immunotherapy of cancer
M Baar, L Coquille, H Mayer, M Hölzel, M Rogava, T Tüting, A Bovier
arXiv preprint arXiv:1505.00452, 2015
The CD58: CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity
P Ho, JC Melms, M Rogava, CJ Frangieh, SB Shah, Z Walsh, O Kyrysyuk, ...
bioRxiv, 2022
Tumor cell intrinsic Toll‐like receptor 4 signaling promotes melanoma progression and metastatic dissemination
M Rogava, AD Braun, TC van der Sluis, N Shridhar, T Tüting, E Gaffal
International Journal of Cancer 150 (1), 142-151, 2022
CXCR3: Here to stay to enhance cancer immunotherapy?
M Rogava, B Izar
EBioMedicine 49, 11-12, 2019
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
J Biermann, JC Melms, AD Amin, Y Wang, LA Caprio, A Karz, S Tagore, ...
Cell 185 (14), 2591-2608. e30, 2022
The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy
J Ruotsalainen, D Lopez‐Ramos, M Rogava, N Shridhar, N Glodde, ...
Clinical & Translational Immunology 10 (4), e1276, 2021
A genetic-metabolic axis of metastatic liver organotropism
M Rogava, JC Melms, S Davis, C Hug, B Ngo, MJ Lee, P Ho, AD Amin, ...
Cancer Research 82 (12_Supplement), 981-981, 2022
Dissecting the ecosystem of treatment-naïve melanoma brain metastasis using multi-modal single-cell analysis
JC Melms, J Biermann, AD Amin, Y Wang, S Tagore, M Andreatta, A Nair, ...
Cancer Research 82 (12_Supplement), 984-984, 2022
CD58: CD2-a multi-dimensional axis in cancer immunotherapy resistance
P Ho, J Melms, M Rogava, S Shah, B Izar
Cancer Research 82 (12_Supplement), 2165-2165, 2022
Tumor cell intrinsic TLR4 signaling promotes melanoma progression and metastatic dissemination.
M Rogava, AD Braun, TC van der Sluis, N Shridhar, T Tüting, E Gaffal
International Journal of Cancer, 2021
Development of antigen specific immunotherapy against melanoma with TRP1 targeted CD4 (+) T cell transfer.
N Shridhar, TC van der Sluis, J Ruotsalainen, B Kruse, S Bonifatius, ...
The system can't perform the operation now. Try again later.
Articles 1–20